119th Congress · introduced in the Senate · Dec 2, 2025
Medical Foods and Formulas Access Act of 2025
Official title from Congress.gov
Latest action (Dec 2, 2025): Read twice and referred to the Committee on Finance.
View on Congress.govPolicy area: Health
Congressional Research Service summary, version: Introduced in Senate (Dec 2, 2025)
Medical Foods and Formulas Access Act of 2025
This bill expands coverage under Medicare, Medicaid, the Children’s Health Insurance Program (CHIP), and the Federal Employees Health Benefits Program to include medically necessary food and associated equipment and supplies.
The bill defines medically necessary food as specially formulated and processed products (e.g., nutritional formulas) prescribed by health care practitioners for individuals who have special dietary requirements because of certain digestive or metabolic disorders or conditions.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Read twice and referred to the Committee on Finance.
Introduced in Senate
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
6 citations.
UNITED MITOCHONDRIAL DISEASE FOUNDATION · lobbying firm or registrant: HOLLAND & KNIGHT LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 17, 2026 · issue area: Health Issues
$20,000
Paid to lobbying firm
…for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · lobbying firm or registrant: SUMMIT HEALTH CARE CONSULTING
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 21, 2026 · issue area: Health Issues
$25,500
Paid to lobbying firm
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192) which applies to ERISA / self-funded plans. Requires health plans to…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
UNITED MITOCHONDRIAL DISEASE FOUNDATION · lobbying firm or registrant: HOLLAND & KNIGHT LLP
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 17, 2026 · issue area: Health Issues
$20,000
Paid to lobbying firm
…for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · lobbying firm or registrant: SUMMIT HEALTH CARE CONSULTING
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted May 12, 2026 · issue area: Health Issues
$25,500
Paid to lobbying firm
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Pediatric indications for biologic products to treat inflammatory bowel disease
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
UNITED MITOCHONDRIAL DISEASE FOUNDATION · lobbying firm or registrant: HOLLAND & KNIGHT LLP
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 16, 2026 · issue area: Health Issues
$20,000
Paid to lobbying firm
…for DoD peer-reviewed medical research and the National Institutes of Health; Improvements in FDA rare disease New Drug Application review process; H.R. 5684 / S. 3304 - Medical Foods and Formulas Access Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NORTH AMERICAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION · lobbying firm or registrant: SUMMIT HEALTH CARE CONSULTING
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 29, 2026 · issue area: Health Issues
$25,500
Paid to lobbying firm
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Cure Hepatitis C Act (S. 1941) Pediatric indications for biologic products to treat inflammatory bowel disease
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing